## Abstract Given the strong etiologic link between highβrisk HPV infection and cervical cancer highβrisk HPV testing is now being considered as an alternative for cytologyβbased cervical cancer screening. Many test systems have been developed that can detect the broad spectrum of hrHPV types in on
Testing for human papillomavirus in cervical cancer screening : A review of indications and methodology
β Scribed by Ha Thanh Nishino; Rosemary H. Tambouret; David C. Wilbur
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 2011
- Tongue
- English
- Weight
- 139 KB
- Volume
- 119
- Category
- Article
- ISSN
- 1934-662X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract We present data on test positivity, relative sensitivity, rates of detection and relative specificity for primary human papillomavirus (HPV) testing with different cutoff levels for test positivity, in comparison to conventional cytology. In 2003β2004, 18,438 women were screened primari
## Abstract Even in the era of highly effective human papillomavirus (HPV) prophylactic vaccines, substantial reduction in worldwide cervical cancer mortality will only be realized if effective early detection and treatment of the millions of women already infected and the millions who may not rece
## Abstract The causal relationship between persistent highβrisk human papillomavirus infection and cervical cancer is widely accepted. HRβHPV DNA testing, alone or in combination with Pap smear testing, may have a role in primary screening. The screening results (VIA, VILI, Pap, and HRβHPV DNA) of
tivity of cervical carcinoma screening and reduce